Spiderwort Selected to Join Elite CELS Valley Ready Program
Admission to Prestigious Program to Bolster Biotechnology Firm’s Global Reach in Life Sciences Ottawa, Canada — November, 22, 2023 — Spiderwort Inc., the biotechnology company innovating in cellulose-based tissue engineering, today announced its acceptance to the prestigious Canadian Entrepreneur in […]
Spiderwort Embarks on November European Tour
Forging Global Partnerships in Regenerative Medicine Ottawa, Canada — October, 27, 2023 — Spiderwort Inc, the biotech company leading in regenerative medicine, will embark on a regional European tour this upcoming November with a focus on building partnerships with researchers, […]
Spiderwort Accepted to Tech Accelerator, MaRS Health Science Portfolio
This important milestone follows Spiderwort’s graduation to Invest Ottawa’s “ScaleUp” venture development program Ottawa — June 6, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been accepted to the prestigious […]
Spiderwort Wins Prestigious Judge's Choice Award at Industry-Leading Octane Medical Aesthetics Tech Forum
This award follow’s Spiderwort’s inaugural presentation to the medical aesthetics industry in the U.S. market. Ottawa — February 7, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been selected as […]
Whiteboard Foods Withdraws from XPRIZE's Feed The Next Billion
Ottawa — February 2, 2023 —After careful consideration, Whiteboard Foods Inc., a subsidiary of Spiderwort Inc, has withdrawn from XPRIZE’s Feed The Next Billion competition, effective Jan 30, 2023. Whiteboard Foods was honoured to be amongst the top 26 semi-finalist […]
Spiderwort secures $13.2M USD in Series A Financing to Accelerate Clinical Trials of Revolutionary Biomaterials
Spiderwort to use funding to advance biotechnology innovations to treat acute spinal cord injuries. OTTAWA – July 12, 2022 – Spiderwort Inc., the biotech company innovating in cellulose-based tissue scaffolding to treat acute spinal cord injuries, today announced the successful […]
FDA grants a Breakthrough Device Designation for Spiderwort Spinal Cord Technology
Spiderwort Inc., a Canadian medical device company developing innovative biomaterials for regenerative medicine, is pleased to announce that the U.S. Food and Drug Administration (FDA) has designated CelluBridgeTM, Spiderwort’s Spinal Cord Scaffold Implant, as a “Breakthrough Device”. The FDA Breakthrough […]
Spiderwort closes $2.5M USD Series Seed financing to continue work on transformative biomaterials
Spiderwort Inc., an innovator in biomaterials, is pleased to announce the closing of their $2.5 million USD Series Seed round financing. The financing was led by Horizons Ventures, and supported by a number of groups, most notably investors from the […]
Spiderwort gaining momentum with the closing of Friends and Family round; naming of key advisors
OTTAWA – June 10, 2019 – Momentum is building as Spiderwort—an innovator in biomaterials that has the potential to transform healthcare—has crossed two major milestones with the closing of its Friends and Family funding round, and the naming of its […]
Please contact us for press kit or media inquiries.
Contact Us